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Effect of Polybrominated Biphenyls on
Hepatic Excretory Function in Rats and
Mice
by S. Z. Cagen* and J. E. Gibsont
Thepurpose ofthisinvestigation wastodetermine theinfluence ofpolybrominated biphenyls (PBBs) on
hepatic excretory function in developing and adult rats and mice. Prenatal or postnatal dietary exposure
to PBBs (50 ppm in diet ofpregnant or lactating mother or in diet ofrat weanlgs) resulted in elevated
lverweight indevelopingrats. In 15-day-old rats thathad beentreated withPBBs, increased liverweight
correlated toenhancedouabain transport from plasmaintobile. Liver weight was also elevated in21,35,
and 49-day-old rats exposed to PBBs, but this effect was not associated with stimulation of ouabain
transport in these animals. However, adult rats fed 100 ppm PBBs for two weeks had sgntiy lower
plasma concentrations ofsulfobromophthalein (BSP) and increased biliary excretion ofBSP, when com-
pared tocontrols. PBBs-fed adult rats also excreted a greater percentage conjugated BSP(BSP-GSH) into
bile. Two week dietary treatment of 100, 150, and 200 ppm PBBs resulted in enhanced initial disappear-
ance ofindocyanine green (ICG) from plasma ofadult mice. However, dietary doses of100 and 200 ppm
PBBs to adult mice was not assoclated with enhanced capacty for ouabain excretion. In contrast, treat-
ment with PBBs through the mother's diet (50 ppm) resulted In an almost twofold increase in cumulative
ouabain excretion in 15-day-old mice. Theresultssuggestthat PBBs stimulate hepatic drugelimination in
rats and mice, but the magnitude of the effect is dependent on age and transported compound.
Introduction
Polybrominated biphenyls (PBBs) are used com-
mercially as flame retardants. The adverse conse-
quences of exposure to PBBs are not completely
known. However, a similarclass ofcompounds, the
polychlorinated biphenyls (PCBs), has been exten-
sively studied, and PBBs may share many of the
biological and toxic properties of PCBs. PCBs are
known to cause chloracne (1) and Yusho disease in
humans (2).
In laboratory animals one of the most prominent
effects of both PBBs and PCBs is induction of a
large increase in liver weight and, in addition,
stimulation of hepatic drug-metabolizing
capabilities (3-6). PBBs are several times more po-
tent than PCBs in stimulating microsomal enzyme
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activity (7). PBBs and PCBs represent a class of
hepatic mixed function oxidase stimulators which
exhibit characteristics of both phenobarbital and
3-methylcholanthrene (5, 6, 8, 9), two agents which
are distinct in their stimulating properties (10, 11).
Microsomal enzyme stimulators such as phenobar-
bital may also enhance bile flow and the biliary
excretion of drugs; 3-methylcholanthrene does not
produce these effects (12-14). The purpose of this
investigation was to determine the influence of
PBBs on the liver as an organ for drug excretion.
Methods
Swiss-Webster mice (30 g) and adult male (200-
250 g), timed pregnant or lactating female (with lit-
ters of 8-10 offspring) Sprague-Dawley rats were
obtained from Spartan Research Animals Inc.
(Haslett, Michigan). PBBs (FireMaster BP-6,
Michigan Chemical Co.) were dissolved in diethyl
etheroracetone (10ml/kgdiet) and werethoroughly
mixed with powdered food pellets over a 10-min
April 1978 233period. The control diet (0 ppm) was powdered food
to which only the solvent had been added.
Hepatic transport of ouabain was determined in
developing rats by quantitating the time dependent
disposition of tritium following administration of
[3H]-ouabain. Developing rats (1.0 mg/kg ouabain)
were administered ouabain via the tail vein and, at
various times following ouabain administration,
animals were anesthetized with ether, a blood sam-
ple was taken (with a heparinized syringe) by car-
diac puncture, and the entire liver and small intes-
tine were rapidly removed. The quantity of
radioactivity in the intestine was measured to esti-
mate biliary excretion of ouabain (15). Samples of
liver, plasma, and intestinal homogenate were sol-
ubilized and when solubilization was complete, the
samples were acidified by the addition of 0.5 ml
4.4M HNO3 and counted in 12 ml oftoluene-Triton
X-100 (2:1) scintillation cocktail (16). In some ex-
periments Dimilume counting solution (Packard In-
strument Co.) was used. The effect of PBBs on
ouabain excretion was determined similarly in de-
veloping and adult mice. Cumulative ouabain
excretion was quantitated by measuring tritium in
the intestine following a tail vein (0.1 mg/kg ouabain
to adult mice) or intraperitoneal (1.0 mg/kg ouabain
to 15-day-old mice) dose of [3H]-ouabain. Radioac-
tivity in all samples was determined with a Pack-
ard Model 3380 liquid scintillation spectrometer
equipped with automatic external standard for
quench correction (Packard Instrument Company,
Downers Grove, Ill.).
The disappearance of indocyanine green (ICG)
(Hynson, Westcott, and Dunning, Inc., Baltimore,
Md.) from plasma was determined in adult mice and
in 21-day-old rats following a single 40 mg/kg dose
ofthe dye via the tail vein. At various times follow-
ing administration of ICG, blood was obtained by
cardiac puncture with a syringe rinsed in sodium
oxalate. Concentration of ICG in plasma was de-
termined by diluting the plasma sample with water
and measuring absorbance of 805 nm (17).
Plasma disappearance and biliary excretion of
sulfobromophthalein (BSP) (Hynson, Westcott, and
Dunning, Inc.) was determined in adult rats follow-
ing a single 120 mg/kg dose of BSP. Rats were
anesthetized with 3 ml/kg of Equi-Thesin (Jensen-
Salsbery, Inc., Kansas City, Mo.), and the femoral
artery and vein were cannulated with PE50
polyethylene tubing and the bile duct cannulated
with PE10 tubing. The animals were placed under a
heat lamp to maintain body temperature. BSP was
injected through the venous cannula and blood
samples (0.3 ml) were drawn into a heparinized
syringe through the arterial cannula at various time
intervals. Bile was collected for 40 min in 10-min
intervals. Plasma and bile samples were analyzed
for BSP by measuring absorbance at 580 nm fol-
lowing appropriate dilution with 0.1N NaOH.
Metabolites ofBSP in bile were separated by paper
chromatography (18) and quantitated by measuring
absorbance at580 nm following elution into distilled
water.
Statistical evaluation of the data was made by
Student's t-test (19). The level of significance was
chosen asp < 0.05.
Results
Two week dietary exposure to as much as 200
ppm PBBs did not affect food consumption or body
weight in adult mice (data not shown), however, a
dose-dependent increase in liver weight was ob-
served following PBBs (Table 1). Fifteen-day-old
mice whose mothers were fed 50 ppm PBBs begin-
ning at birth also had significantly elevated liver
weight (Table 1). In developing rats, exposure to
PBBs resulted in significant increases in liver
weight to body weight ratios when compared to
controls on postnatal days 15, 21, 35, and 49 (Table
1). In addition, when compared to 15-day-old rat
neonates whose natural and foster mother received
no dietary PBBs, a significant elevation of liver to
body weight ratio was detected in 15-day-old rats
exposed to PBBs prenatally, postnatally, and com-
bined pre- and postnatally (Table 1).
The effect ofPBBs on elimination ofouabain from
plasma of 15, 21, 35, and 49-day-old rats is depicted
in Figure 1. Exposure to PBBs began at birth by
addition of 50 ppm PBBs to the mother's diet. Ex-
posure was continued at postnatal day 28 through
the weanling's diet. Plasma concentrations of oua-
bain were significantly lower than control values in
PBB-exposed 15-day-old rats 3, 20, and 40 min fol-
lowing ouabain injection and in PBB-treated 21-
day-old rats 3 min following ouabain injection. In
contrast, plasma concentrations of ouabain in 35
and 49 day old PBB-exposed rats were not signif-
icantly different from plasma ouabain concentra-
tions in the controls (Fig. 1). When compared to
control rats of the same age, cumulative 40-min in-
testinal ouabain content, an estimate of biliary
excretion of ouabain, was significantly elevated in
PBB-exposed 15-day-old rats but not in 21, 35, and
49-day-old PBB-exposed animals (Table 2).
Following a single bolus ouabain injection,
plasma concentrations ofouabain were significantly
lower in 15-day-old rats exposed to PBBs prenatally
(from day 8 ofgestation to birth) and/or postnatally
(from birth to postnatal day 15) when compared to
15-day-old controls (0-0) (Fig. 2). Among all of the
dietary treatments, prenatal exposure to PBBs
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Liver weight/ % of
Age, PBBs, body weight, respective
Species days ppma Duration % control
Mouse 15 0 15 days (postnatal) 4.2 t 0.1
15 50 15 days (postnatal) 8.4 t 0.2b 200
Adult 0 2 weeks 4.8 ± 0.1
Adult 50 2 weeks 6.8 ± 0.2b 142
Adult 100 2 weeks 8.2 +0.2b 171
Adult 150 2 weeks 8.9 ± 0.jb 185
Adult 200 2 weeks 10.4 + 0.lb 217
Rat 15 0 15 days (postnatal) 3.2 ± 0.1
15 50 15 days (postnatal) 4.6 ± 0.1b 144
15 50 15 days (prenatal) 3.5 ± 0.1b 109
15 50 30 days (pre+postnatal) 5.0 ± 0.1b 156
21 0 21 days (postnatal) 4.0 ± 0.1
21 50 21 days (postnatal) 6.4 ± 0.1lb 160
35 0 35 days (postnatal) 4.0 ± 0.1
35 50 35 days (postnatal) 6.2 t 0.2b 155
49 0 49 days (postnatal) 4.7 ± 0.1
49 50 49 days (postnatal) 6.6 ± 0.1b 140
a Concentration of PBBs in diet (animals younger than 28 days, weaning age, received PBBs through mother's diet).
b Significantly different from 0 ppm PBBs (p < 0.05).
(50-0) was least effective in enhancing ouabain
elimination from plasma. Similarly, cumulative
40-min intestinal ouabain content, an estimate of
biliary excretion ofouabain, was highest in rats ex-
posed to PBBs postnatally and was affected by pre-
natal PBB exposure to a lesser, but statistically sig-
nificant, extent when compared to controls (Table
2). When compared to values from control (0-0)
rats, 15-day-old animals exposed to PBBs postnat-
ally (0-50), or pre- and postnatally (50-50) had sig-
nificantly higher hepatic ouabain content 3 min fol-
lowing ouabain injection (Fig. 3). These increases
reflect the effect ofPBBs on liver weight (Table 1).
Similar results were observed in developing mice.
Elevation in cumulative excretion of ouabain was
observed in 15-day-old but not adult mice exposed
to PBBs (Table 2).
In adult mice and 21-day-old rats, treatment with
PBBs resulted in enhanced initial disappearance of
ICG from plasma (Table 3 and Fig. 4). Plasma con-
centrations of ICG were significantly lower than
control values 10 and 15 min following injection of
ICG in mice fed 100 and 150 ppm PBBs. In mice fed
200 ppm PBBs, plasma concentration of ICG was
significantly lower than control value 15 min fol-
lowing ICG injection (Fig. 4). The disappearance of
ICG from plasma of21-day-old control rats and rats
exposed to PBBs is depicted in Table 3 by the rate
of ICG elimination from plasma. The rate of ICG
elimination from plasma was significantly greater in
21-day animals whose mothers were fed 50 ppm
PBBs (Table 3).
Two week dietary exposure of adult rats to 100
ppm PBBs resulted in enhanced elimination ofBSP
from plasma and increased biliary excretion ofBSP
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Table 2. Effect of polybrominated biphenyls (PBBs) on
cumulative hepatic excretion of ouabain."
Dietary Ouabain
Age, PBBs, excretion,
Species days ppm Duration % ofdose
Rat 15 O0 15 days (postnatal) 12.2 ± 1.1
15 50b 15 days (postnatal) 38.9 1.6d
15 50- tY 15 days (postnatal) 17.4 ± 1.4d
15 0-50r 15 days (postnatal) 27.4 ±1.Id
15 50-50r 30 days (pre+postnatal) 27.7 + 2.8d
21 0" 21 days (postnatal) 17.8 e0.6
21 50 21 days (postnatal) 20.2 2.6
35 0" 35 days (postnatal) 21.1 ± 5.4
35 50" 35 days (postnatal) 20.6 ± 3.2
49 O0 49 days (postnatal) 34.3 ± 1.5
49 501 49 days (postnatal) 39.8 + 1.9
Mouse 15 Ob 15 days (postnatal)' 24.7 ± 3.6
15 50 15days(postnatal)b 46.3 + 1.3d
Adult 0 2weeksb 30.7 ± 3.4
Adult 100b 2 weeksb 35.9 ± 2.5
Adult 200b 2 weeksb 39.1 ± 2.0
a [3H]-Ouabain was injected via the tail vein (0.1 mg/kg to
adult mice or 1.0 mg/kg to developing rats) or intraperitoneally
(1.0 mg/kg to 15-day-old mice) and after 40 min (in developing
rats), 60 min (in adult mice) or 120 min (in 15-day-old mice),
intestine was analyzed for tritium.
b Concentration ofPBBs in diet(animals youngerthan 28 days,
weaning age, received PBBs through mother's diet).
c Pregnant rats were fed 0 or 50 ppm PBBs from dav 8 of
gestation to postnatal day 15. All litters were cross-fostered at-
birth to give litters born to and nursed by mothers with the fol-
lowing dietary exposures: 0 ppm prenatal, 0 ppm postnatal (0-0);
50 ppm prenatal, 0 ppm postnatal (50-0); 0 ppm prenatal, 50 ppm
postnatal (0-50); 50 ppm prenatal, 50 ppm postnatal (50-50).
d Significantly different from 0 ppm PBBs atcorrespondingage
(p < 0.05).
(Table 4). In addition, PBB-fed adult rats excreted a
greater percentage conjugated BSP into bile (Table
4).
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FIGURE 2. Effect ofpre- and/or postnatal exposure to polybrom-
inated biphenyls (PBBs) on elimination of [3H]-ouabain from
plasma of 15-day-old rats. Pregnant rats were fed 0 or50 ppm
PBBs from day 8 ofgestation to postnatal day 15. All litters
were cross-fostered at birth to give litters born to and nursed
\' ^ 1<.~~~~I by mothers with the following dietary exposures: (0-0) 0 ppm
\0., 1 \ prenatal, 0 ppm postnatal; (50-0) 50 ppm prenatal, 0 ppm
o \ \ postnatal; (0-50) 0 ppm prenatal, 50 postnatal (50-50), 50 ppm
N,, Ab prenatal, 50 ppm postnatal. Rats were administered [3H]- *s ouabain(I mg/kg) via the tail vein andfollowing 3, 20, and 40
9°o min, blood was obtained by cardiac puncture and plasma
3 20 40 3 20 40 samples analyzed fortritium (ouabain). Each point represents
the mean for six to eight rats obtained from four litters. Stan-
dard error (not shown for clarity) was approximately 10%o of
1. Effect of exposure to polybrominated biphenyls mean value. The asterisks (*) indicates plasma ouabain con-
Is) on elimination of [3H]-ouabain from plasma ofrats of centration significantly different from values obtained from
ranging from 15 to 49 days: (--) 0 ppm PBBs; (-) 50 0-0 (p < 0.05).
ppm PBBs. Young rats were exposed to PBBs by placement of
50 ppm PBBs in diet of lactating mother. At weaning, post-
natal day 28, rats were weaned onto the same diet fed to
mother. Rats were administered [3H]-ouabain (1 mg/kg) via
the tail vein and following 3, 20, and 40 min, blood was ob-
tained by cardiac puncture and plasma samples analyzed for
tritium (ouabain). Each point represents the mean + S.E. for
four rats obtained from four litters. When standard error bars
are not shown, standard error was smaller than the diameter
of the point. The asterisks (*) indicates plasma ouabain con-
centrations significantly different from values obtained from
rats exposed to 0 ppm PBBs (p < 0.05).
Discussion
It has been demonstrated that PBBs are potent
stimulators of hepatic drug metabolism (5-7). The
results of this investigation demonstrate that treat-
ment with PBBs may also result in stimulation of
hepatic excretory function.
Prenatal and/or postnatal exposure to PBBs re-
sulted in stimulation of hepatic excretory function
in 15-day-old rats (Fig. 1 and Table 2) and 15-day-old
mice (Table 2). This was demonstrated by enhanced
rate of elimination of ouabain from plasma (Figs. 1
and 2) and increased cumulative intestinal ouabain
content (Table 2) in 15-day-old treated animals
when compared to 15-day-old controls.
The effect of PBBs on ouabain transport in 15-
day-old rats appeared to parallel the effect on liver
mass. Stimulation of ouabain transport was most
evident in rats receiving postnatal exposure to
PBBs, and this effect coincided with the greater
elevation in liver weight in these animals when
compared to rats receiving prenatal (50-0) exposure
(Figs. 1 and 2 and Table 1). However, the large
increase in liver mass in 21, 35, and 49-day-old rats
exposed to PBBs (Table 1) was not associated with
enhanced elimination ofouabain from plasma or in-
creased ouabain excretion (Fig. I and Table 2).
Moreover, two week dietary exposure to 100 or 200
ppm PBBs to adult mice resulted in a marked in-
crease in liver mass (Table 1) but no effect on the
ability to excrete ouabain (Table 2). Thus, two fac-
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FIGURE 3. Effect ofpre- and/or postnatal exposure to polybrom-
inated biphenyls (PBBs) on hepatic content of [3H]-ouabain
in 15-day-old rats. Pregnant rats were fed 0 or 50 ppm PBBs
from day 8 of gestation to postnatal day 15. All litters were
cross-fostered at birth to give litters born to and nursed by
mothers with the following dietary exposures: (0-0) 0 ppm
prenatal, 0 ppm postnatal; (50-0) 50 ppm prenatal, 0 ppm
postnatal; (0-50) 0 ppm prenatal, 50 ppm postnatal; (50-50)
50 ppm prenatal, 50 ppm prenatal. Rats were adminis-
tered [3H]-ouabain (I mg/kg) via the tail vein and following 3,
20, and 40 min, samples of liver were analyzed for tritium
(ouabain). Each point represents the meanforsix to eight rats
obtained from four litters. Standard error (not shown for
clarity) was approximately 10%o ofmean value. The asterisks
(*) indicates hepatic content ofouabain significantly different
from values obtained from 0-0 (p< 0.05).
tors that may be important in stimulation of drug
transport following PBBs are liver mass and age.
Elimination of xenobiotics from plasma into bile
occurs in a stepwise manner. Drug transport into
bile requires specific uptake into liver, intrahepatic
metabolism and storage, and finally secretion from
liver into bile. Ouabain is not metabolized in the
liver prior to biliary excretion in rats (21) or mice
(22); however, treatment with PBBs resulted in a
significant increase in hepatic ouabain content
(Jug/kg body weight) 3 min following ouabain ad-
ministration in 15-day-old rats (Fig. 3). The increase
in hepatic ouabain content was due, to some extent,
to increased ouabain concentration (data not
shown) but the magnitude of this effect mainly re-
flected the effect ofPBBs on liverweight (Table 1).
Nonetheless, these data suggest that stimulation of
ouabain transport in 15-day-old rats may be at-
tributed to enhanced ouabain uptake into liver.
The mechanisms for hepatic uptake may also be
stimulated following PBBs in the older rats. The
initial rate of removal of indocyanine green (ICG)
from plasma was enhanced following exposure to
PBBs in 21-day-old rats (Table 3). Since the initial
rate ofelimination ofdrugs from plasma represents
hepatic uptake (23), it is likely that treatment with
PBBs resulted in enhanced uptake capacity in these
animals. Following PBBs, stimulation of hepatic
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FIGURE 4. Disappearance of indocyanine green (ICG) from
plasma of mice fed various doses of polybrominated
biphenyls (PBBS) for 2 weeks prior to administration of ICG
(40 mg/kg, iv). (.) 0 PBBs; (o) 50 ppm PBBs; (A) 100 ppm
PBB; (o) 150ppm PBB; (x) 200 ppm PBBs. Each point repre-
sents the mean for 3-12 mice. Standard errors (not shown for
clarity) were approximately 10o of mean values. The as-
terisks (*) indicate plasma ICG concentration significantly
different from 0 ppm PBBs (p <0.05). From Cagen et al. (34).
Table 3. Initial rate ofelimination of ICG from plasma in
21-day-old rats exposed to dietary PBBs.
Rate of
elimination (±) Fiducial Ti,
PBBs, ppma (slope)b limits min
0 -0.025 0.010 10.5
50 -0.042c 0.013 7.0
a Concentration of PBBs in mother's diet from day of birth
until day of experiment.
b ICG (40 mg/kg) injected via the tail vein and rate ofelimina-
tion of ICG from plasma determined from plasma ICG concen-
trations at 1, 5, 10, and 15 min following injection by the method
ofleast squares.
c Significantly different from 0 ppm PBBs (p < 0.05).
uptake in 21-day-old rats was not associated with
enhanced ouabain excretion (Table 2) and was as-
sociated with significantly lower plasma ouabain
concentration at only the earliest (3 min) time inter-
val (Fig. 1). Two week dietary exposure to PBBs in
adult mice resulted in enhanced initial disappear-
ance of ICG from plasma (Fig. 4), which provides
April 1978 237Table 4. Elinlnation ofsulfobromophthalein (BSP) from plasma and biL;ary excretion of BSP folowing PBBs in adult rats.
Time following BSP administrationb PBBs,
ppma Parameter 3 min 10 min 20 min 30 min 40 min
0 BSP remaining in
plasma, mg/100 ml 157.8 t 1.8 75.8 + 1.4 48.5 t 1.9 39.4 t 1.4 33.0 t 1.9
100 BSP remaining in
plasma, mg/100 ml 131.8 t 6.lc 61.8 t 2.7c 33.2 t 2.4c 18.9 t 2.6c 7.3 t 2.01c
0 BSP excretion,
,umole/min/kg 0.16 t 0.06 0.78 ± 0.15 0.83 ± 0.13 0.96 ± 0.04
100 BSP excretion,
,umole/min/kg 0.71 + 0.06c 1.86 ± 0.09' 2.27 + 0.24c 2.22 ± 0.11I
0 Metabolites of
BSPinbile,% 24+16 64±8 63±8 76±3
100 Metabolites of
BSPinbile,% 74+ 4c 89±3 c 92±2 c 96+ IC
a Concentration ofPBBs in diet ofadult rats for 2 weeks.
b BSP (120 mg/kg) was injected into the femoral vein of anesthetized rats and at various times following BSP administration, the
amount ofBSP in plasma and bile was determined.
c Significantly different from 0 ppm PBBs (p <0.05).
additional evidence for enhanced uptake capacity
following exposure to PBBs.
It is difficult to determine to what extent en-
hanced uptake capacity is due to specific stimula-
tion of transport mechanisms or increased liver
mass. Stimulation of drug transport following
phenobarbital has been attributed, by some, to be
due to increased hepatic blood flow resulting from a
greater liver mass (24-26). A similar relationship
may exist following PBBs.
In adult rats, Meijer et al. (27) suggested that the
rate-limiting step for ouabain excretion from blood
into bile is biliary excretion (not hepatic uptake).
Thus, stimulation of uptake mechanisms in adult
mice and rats following PBBs might notbe expected
to enhance overall excretion of ouabain into bile.
Newborn rats (28, 29) and possibly newborn mice
(20) are immature in their ability to take up com-
pounds into liver, and thus, stimulation of uptake
following PBBs may be more important for overall
transport in these animals (Table 2).
Exposure ofadult rats to 100 ppm PBBs resulted
in enhanced plasma disappearance and biliary
excretion (Table 4) of BSP. Moreover, treated rats
excreted a greater percentage metabolized BSP
than controls (Table4). Whelan et al. (30) suggested
that BSP metabolism (conjugation to glutathione) is
rate-limiting in BSP transport from blood into bile.
Since exposure to PBBs resulted in increased
biliaryexcretion ofBSP metabolites (Table4) andin
vitro conjugation ofBSPis stimulated in rats treated
withPBBs(31), the effectofPBBs onBSP transport
may be primarily attributed to increased metab-
olism.
The results ofthis investigation therefore demon-
strate that PBBs have the capacity to alter the he-
patic drug elimination processes, but the magnitude
of the effect is dependent on age and transported
compound. Since many drugs and environmental
chemicals are excreted by the liver (32, 33), the po-
tential exists for chemical interactions following ex-
posure to PBBs. It is noteworthy that 15-day-old
rats whose mothers were exposed to 50 and 100
ppm PBBs were protected against ouabain-induced
lethality (20).
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